Sygnature Discovery has appointed Dr Andy Black as non-executive Chairman. Andy will work closely with the Board and senior team to further develop the future growth strategy of the organisation. In October 2017, Phoenix Equity Partners, a leading private equity investor in medium-sized, UK-based companies, invested...
Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has appointed Andy Lindstrom as Director of Marketing to develop and lead the marketing strategy for the business. Andy holds a BA in Communications and Marketing from the University of Gävle, Sweden,...
Five companies from across the region were delighted to be selected as winners at last night’s Medilink East Midlands Business Awards. The Awards, which are held as part of the region’s premier life science event, Innovation Day, recognise organisations in the sector who in the past...
[gallery ids="17871,17870"] Fledgling businesses shared £1 million in funding from partner organisations following the latest Scottish EDGE pitching competition. Twenty firms pitched their ideas live at Scottish EDGE to a panel of business heavyweights made up of: Jim McColl of Clyde Blowers, Steve Dunlop of Scottish Enterprise,...
BBC acknowledges Azotic in World news broadcast BioCity Nottingham based Azotic Technologies, the UK-based global ag-tech company, is launching its Envita™ natural-nitrogen fixing technology commercially across North America in autumn 2018 following extensive trials, under the Envita™ Growing Programme, across approximately 3,000 acres involving 58 farmers growing either corn or...
Biomedical research company Alderley Analytical has received £300k funding from the Northern Powerhouse Investment Fund. The Macclesfield-based company, which currently employs 21 people, is expecting to create at least six jobs in the coming months. Alderley Analytical secured the six-figure boost through NPIF - FW Capital...
Sygnature Discovery, the UK's largest independent provider of integrated drug discovery resource and expertise, has appointed Dr Bill Marathias as Vice President of Business Development for the US to assist with the company’s ambitious international expansion plans. Sygnature Discovery already has a growing client base in...
BioCity, Glasgow based BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology BDD Pharma today announced that it has signed an agreement to license OralogiK™, its timed drug delivery technology, to Novartis Pharma AG for the development of a new product containing an undisclosed...
Accelerator programme graduate, BioCity, Glasgow based novosound has raised £1.5m in a seed investment round. The winner of last year's Converge Challenge competition, novosound will use the money to expand its team and bring its ultrasound sensors to the market. The bulk of the cash has been supplied...
The Antibody Company has received IBioIC investment to look at production of a food safety test using gold nanoparticles and antibodies. The Industrial Biotechnology Innovation Centre (IBioIC) awarded funding of £57,500 (€66k) to the microenterprise based at BioCity, Glasgow. The Antibody Company and the University of Strathclyde...